Number of observations | Number (%) | OR (95% CI) | p Value | ||
Intervention (n = 51) | Control (n = 75) | ||||
ACE inhibitor | |||||
Baseline | 126 | 33 (64.7) | 40 (53.3) | 0.41 (0.21 to 1.37) | 0.1531 |
Follow-up | 126 | 33 (64.7) | 51 (68.0) | ||
ACE or ARB* | |||||
Baseline | 126 | 39 (76.5) | 50 (66.7) | 0.57 (0.14 to 2.32) | 0.4312 |
Follow-up | 126 | 43 (84.3) | 62 (82.7) | ||
Beta-blocker | |||||
Baseline | 126 | 14 (27.5) | 24 (32.0) | 1.72 (0.25 to 11.82) | 0.5802 |
Follow-up | 126 | 20 (39.2) | 28 (37.3) | ||
Carvedilol or bisoprolol | |||||
Baseline | 126 | 9 (17.6) | 14 (18.7) | 2.75 (0.63 to 11.86) | 0.1721 |
Follow-up | 126 | 17 (33.3) | 18 (24.0) |
Values are number (percentage).
*Angiotensin receptor blocker.